Skip to main content
. 2018 Sep 2;10(3):143. doi: 10.3390/pharmaceutics10030143

Table 2.

Matrix effects and recoveries of CGA, NCGA, CCGA, CA, CA-3-G, CA-4-G, FA, and FA-d3 (IS) using six different rat plasma (n = 6).

Compounds Nominal Concentration (ng/mL) Matrix Effect a (%) Recovery b
(Mean ± SD, %)
Mean CV (%)
CGA 1.5 91.6 7.6 63.0 ± 6.3
25 92.0 11.0 71.7 ± 6.9
160 87.1 5.4 71.9 ± 9.4
NCGA 1.5 96.1 3.6 41.4 ± 4.0
25 90.8 3.2 43.4 ± 3.7
160 89.0 7.1 41.8 ± 1.4
CCGA 7.5 98.0 6.6 61.5 ± 5.2
125 92.4 2.2 63.0 ± 7.8
800 89.3 6.2 65.2 ± 5.7
CA 7.5 87.7 7.2 94.0 ± 9.9
125 93.0 11.8 86.1 ± 10.4
800 88.6 6.2 91.2 ± 6.3
CA-3-G 7.5 95.9 2.0 46.5 ± 4.3
125 95.8 7.4 51.2 ± 3.4
800 88.5 8.5 52.8 ± 4.2
CA-4-G 7.5 92.7 1.7 51.3 ± 6.0
125 95.6 5.3 53.0 ± 3.4
800 86.5 9.7 55.8 ± 4.2
FA 37.5 96.8 2.2 93.3 ± 8.7
625 87.5 8.4 96.9 ± 8.7
4000 97.5 8.6 97.4 ± 4.2
FA-d3 20 96.0 5.4 100.1 ± 2.0

a Matrix effect expressed as the ratio of the mean peak area of an analyte spiked post-extraction to the mean peak area of same analyte standards multiplied by 100. b Recovery calculated as the ratio of the mean peak area of an analyte–spiked plasma prior to liquid–liquid extraction to the mean peak of an analyte spiked after liquid-liquid extraction of blank plasma multiplied by 100.